Drug Promotion: Sponsors Are Running Afoul Of US FDA’s CFL Guidance

Recent Office of Prescription Drug Promotion enforcement letters provide several learnings, including the need to be aware of a product’s regulatory history and competitive landscape when developing promotions that are consistent with FDA-labeling, experts said.